Insider Filing: David S. Simmons Receives 22,820 RSUs at Viatris
Rhea-AI Filing Summary
Viatris director David S. Simmons reported the acquisition of 22,820 restricted stock units (RSUs) with a transaction date of 08/11/2025. Each RSU represents the right to receive one share of Viatris common stock at a $0 conversion price, and the award is scheduled to vest on March 6, 2026, at which point the RSUs convert into common shares.
The Form 4 shows this as an insider equity award reported by a single reporting person and executed under a power of attorney. The filing documents an equity grant/vesting schedule rather than a sale or cash purchase.
Positive
- 22,820 RSUs acquired, converting to common stock upon vesting
- RSUs have a clear vesting date of March 6, 2026, providing transparent timing for potential share issuance
Negative
- None.
Insights
TL;DR: A director received 22,820 RSUs; this is a compensation grant with limited immediate market impact.
The reported transaction is an equity award of 22,820 RSUs that convert one-for-one into common stock and vest on March 6, 2026. As this is a grant rather than a sale, it does not indicate insider selling pressure. The award increases potential future dilution when the RSUs vest and shares are issued, but the filing does not quantify current total outstanding shares or percentage dilution, so material impact cannot be assessed from this Form 4 alone.
TL;DR: Standard director RSU award disclosed; vesting date and direct ownership are clearly reported.
The disclosure identifies the reporting person as a director and records the award as directly beneficially owned following the reported transaction. The use of a power of attorney for filing is noted. This is a routine compensation disclosure that provides transparency about executive/director incentives and vesting timing, but the filing contains no indication of unusual governance events or material changes to control.